Financials in USD. Standardized financial statements.
A compact view of how Sabra Health Care REIT, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $774.63M | $703.24M | $647.51M | $624.81M | $569.54M | $598.57M | $668.18M | $623.41M | $405.65M | $260.53M |
| Revenue Growth? | +10.2% | +8.6% | +3.6% | +9.7% | -4.8% | -10.4% | +7.2% | +53.7% | +55.7% | 0.0% |
| Cost of Revenue? | $271.11M | $227.09M | $195.25M | $162.61M | $141.20M | $131.55M | $109.71M | $49.55M | $17.86M | $5.70M |
| Gross Profit? | $503.53M | $476.15M | $452.27M | $462.20M | $428.34M | $467.02M | $558.48M | $573.86M | $387.79M | $254.82M |
| Gross Margin? | +65.0% | +67.7% | +69.8% | +74.0% | +75.2% | +78.0% | +83.6% | +92.1% | +95.6% | +97.8% |
| Operating Expenses? | $239.66M | $219.12M | $230.56M | $227.36M | $217.59M | $467.02M | $30.89M | $266.91M | $163.40M | $93.93M |
| Operating Income? | $263.87M | $257.03M | $221.71M | $234.84M | $210.75M | $0 | $527.59M | $306.95M | $224.39M | $160.89M |
| EBITDA? | $456.83M | $412.61M | $311.81M | $216.89M | $166.21M | $416.29M | $527.08M | $511.70M | $353.93M | $285.39M |
| Income Before Tax | $157.35M | $127.72M | $15.76M | -$76.36M | -$111.41M | $139.13M | $72.42M | $282.13M | $159.02M | $70.20M |
| Income Tax Expense | $1.84M | $1.00M | $2.00M | $1.24M | $1.84M | $710,000 | $3.40M | $3.01M | $651,000 | $75.48M |
| Net Income? | $155.61M | $126.71M | $13.76M | -$77.61M | -$113.26M | $138.42M | $69.00M | $279.08M | $158.38M | $70.28M |
| EPS? | $0.64 | $0.54 | $0.06 | $-0.34 | $-0.52 | $0.67 | $0.37 | $1.57 | $1.40 | $0.92 |
| Diluted EPS? | $0.64 | $0.54 | $0.06 | $-0.34 | $-0.52 | $0.67 | $0.37 | $1.56 | $1.40 | $0.92 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality